Coordinated by Assoc. Prof. Gülay SEZER, a faculty member at the Department of Medical Pharmacology/ERU Faculty of Medicine, the project called “In vitro and In vivo Investigation of the Efficacy of Targeted Nanoparticles Containing Minocycline and Cisplatin in Triple Negative Breast Cancer”, in which Assoc. Prof. Kadriye KIZILBEY (Acıbadem Mehmet Ali Aydınlar University, Faculty of Engineering and Natural Sciences, Department of Basic Sciences), Prof. Dr. Arzu Hanım YAY (ERU/Department of Histology and Embryology), Assoc. Prof. Çiğdem YÜCEL (ERU Faculty of Pharmacy/Department of Pharmaceutical Technology), and Lect. Dr. Dilek BAHAR (ERU Genome and Stem Cell Center) are researchers, and Prof. Dr. Zuhal HAMURCU (ERU/Department of Medical Biology), Prof. Dr. Serap ACAR DERMAN (Yıldız Technical University, Faculty of Chemistry and Metallurgy, Department of Bioengineering), and Assoc. Prof. Murat TOPUZOĞULLARI (Yıldız Technical University, Faculty of Chemistry and Metallurgy, Department of Bioengineering) are consultants, has been entitled to be supported as part of the TUBITAK 1001 Program.

We congratulate our researcher and her team and wish them continued success.